Diversion Quarterly — Q2 2020

Olivia StearnBlog

Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly basis to provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of June 30, 2020. Data was pulled from health systems across the United States.

Hospital Pharmacy Operations Report and Covid-19: Shortages and Diversion Risk are Top Concern

Jenny HarlettBlog

This week Kit Check released the results of our 2019 Hospital Pharmacy Operations Report (HPOR), and annual look at the top issues facing hospital pharmacists. Kit Check Director of Clinical Solutions Jennifer Symon, R.Ph, MBA, FACHE, discusses the results of the survey: Notably, drug diversion detection and prevention remains a top priority. In the current COVID-19 crisis, ensuring staff and … Read More

Using AI to Prevent Diversion, Improve Efficiency, and Ensure Safety

Jenny HarlettBlog

A recent Pharmacy Technology Report article highlighted how Kit Check partner Children’s Hospital of the King’s Daughters is using our AI-based solution, Bluesight for Controlled Substances to ensure that medications make it to the young patients who need them. CHKD has been using Bluesight for Controlled Substances to track controlled substances and detect diversion risk in its 20 ORs. Bluesight … Read More

Diversion Quarterly — Q1 2020

Jenny HarlettBlog

Kit Check is pulling data from its Bluesight™ for Controlled Substances platform on a quarterly basis that will provide insight into the types of diversions and investigations that may be occurring in hospital pharmacies. The following information is as of March 31, 2020. Data was pulled from health systems across the United States. Totals Numbers based on Kit Check’s earliest … Read More

2020 KLAS Category Leader — Drug Diversion Monitoring

Bluesight for Controlled Substances Named Category Leader in Best in KLAS 2020 Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today released its 2020 Best in KLAS report. We are thrilled to announce that Bluesight for Controlled Substances received the honor of Category Leader in Drug Diversion Monitoring Solutions, earning a rating of 93.9 out of 100! The annual Best in KLAS report analyzes data from customers to provide accurate perspective on the products … Read More

Kit Check’s Bluesight for Controlled Substances™ Named Category Leader for Drug Diversion Monitoring in 2020 Best in KLAS Report

Jenny HarlettPress Release

KLAS report ranks Kit Check as the top performer with 93.9 rating for consistently delivering on product support, customer loyalty and quality of operations.   WASHINGTON (January 31, 2020) — Kit Check™, the leader in automated and intelligent medication management solutions, today announced that its Bluesight™ for Controlled Substances diversion detection software has been named the Category Leader in Drug Diversion … Read More

Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking

Jenny HarlettPress Release

WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for hospitals, today announced that Vizient has extended its agreement with the company for its Bluesight for Controlled Substances (BCS) as well as Kit Check’s kit and tray processing system. Vizient is the nation’s leading health care performance improvement company serving more than 50% of the … Read More

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Jenny HarlettPress Release

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 WASHINGTON (August 20, 2019) — Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances (Bluesight) diversion prevention and controlled substance management solution has been recognized by leading analyst firm KLAS Research in its next-generation solution … Read More

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report

Jenny HarlettBlog

Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. We are thrilled to announce that Bluesight for Controlled Substances received top marks, earning a rating of 93.2* out of 100! KLAS’s “Drug Diversion Monitoring 2019, An Early Look at Emerging Vs. Established Technology” highlights hospitals and health systems’ need for drug diversion monitoring technology, … Read More

New Bluesight for Controlled Substances Feature: Investigation Portfolios

Jenny HarlettBlog

We are excited to announce the launch of our newest feature for the Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Designed to support ASHP investigation guidelines, the Investigations Portfolio dashboard allows hospital diversion teams to collaborate with each other throughout the process, ensuring thorough, unbiased investigations and adherence to established procedures. Many hospitals … Read More

Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios

Jenny HarlettPress Release

Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 — Kit Check, the leader in automated medication management solutions for hospitals, today announced the addition of a new feature to its Bluesight for Controlled Substances (BCS) medication tracking and diversion risk detection platform: Investigation Portfolios. Bluesight for Controlled Substances’ Investigation Portfolios tool was designed … Read More

Webinar: The Diversion Gap and What to Do About It

Jenny HarlettBlog

Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what we call the diversion gap—the space between controlled substance dispense activity and documentation where inventory can go missing. Hosted by IHFDA, the webinar covers key findings from our 2018 Hospital Pharmacy Operations Report, especially as they relate to the opioid crisis. AJ discusses the need … Read More